In his welcoming remarks to participants and guests of the next Technical Committee which has been held in Tashkent on February 22, Mr. Wim Riepma, Head of Cooperation of the Delegation of the European Union to Uzbekistan, said that the partnership between the European Union and Uzbekistan has grown stronger throughout the years and became a cornerstone of the EU’s goal of fostering resilience and prosperity in Central Asia and beyond. He added that successful drug demand and harm reduction as well as addressing drug trafficking, contribute to this goal. Uzbekistan is strategically located vis-à-vis major production areas of opioids, (met)-amphetamines and synthetic drugs and therefore the CADAP Programme continues to be of high relevance. He thanked and commended the government of Uzbekistan for their unwavering support.
Ms Dina Mamutova, specialist of the international department, National Information-Analytical Center on Drug Control under the Cabinet of Ministers of the Republic of Uzbekistan, mentioned that within the implementation of the CADAP phases, visible results have been achieved in the area of prevention, in the reduction of the spread of drug use among the population. “Today we face new challenges and threats requiring a joint international response. In doing so, we consider it possible to continue our fruitful cooperation under the Financial Agreement for the implementation of the 7 phase of the CADAP Programme in the several key areas” – she said.
